Invention Grant
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/docs/US/2023-06-13/US11672780B2/abs.jpg.600x600.jpg)
- Patent Title: [1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds
-
Application No.: US17113495Application Date: 2020-12-07
-
Publication No.: US11672780B2Publication Date: 2023-06-13
- Inventor: Alaric J. Dyckman , Dharmpal S. Dodd , Tasir Shamsul Haque , Louis J. Lombardo , John E. Macor , Christopher P. Mussari , Laxman Pasunoori , Sreekantha Ratna Kumar , Trevor C. Sherwood , Shoshana L. Posy , Ramesh Kumar Sistla , Subramanya Hegde , Anupama Kandhi Ramachandra Reddy
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Gary Greenblatt
- Main IPC: A61K31/4196
- IPC: A61K31/4196 ; A61K31/437 ; A61K31/4427 ; A61K45/06 ; C07D471/04 ; C07D249/00
![[1,2,4]triazolo[1,5-a]pyridinyl substituted indole compounds](/abs-image/US/2023/06/13/US11672780B2/abs.jpg.150x150.jpg)
Abstract:
Disclosed are compounds of Formula (I)
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
or a salt thereof, wherein R1, R2, R3, R4, R5, m, n, and p are defined herein. Also disclosed are methods of using such compounds as inhibitors of signaling through Toll-like receptor 7, or 8, or 9, and pharmaceutical compositions comprising such compounds. These compounds are useful in treating inflammatory and autoimmune diseases.
Public/Granted literature
- US20210085651A1 [1,2,4]TRIAZOLO[1,5-A]PYRIDINYL SUBSTITUTED INDOLE COMPOUNDS Public/Granted day:2021-03-25
Information query
